Exodus Point Capital Management, LP Lannett CO Inc Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.75 - $1.77 $21,769 - $51,376	-29,026 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.56 - $2.93 $65,131 - $122,330	-41,751 Reduced 58.99%	29,026 $47,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.83 $46,117 - $76,545	15,848 Added 28.85%	70,777 $212,000
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $86,823 - $119,512	20,821 Added 61.04%	54,929 $257,000
Q1 2021 May 17, 2021	BUY	$5.28 - $9.64 $180,090 - $328,801	34,108 New	34,108 $180,000
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $213,099 - $321,531	-25,100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $54,684 - $141,806	9,800 Added 64.05%	25,100 $281,000
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $79,866 - $138,924	15,300 New	15,300 $93,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.